ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1164508 BOSTON, MA

Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$46,523,684

+$3,124,400 QoQ

Shares Held

562,016

-0.4% QoQ

Ownership

2.45%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 303 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,137,442	$225,456,582
2	VTRS	Viatris Inc	8,371,218	$132,934,941
3	HLN	Haleon plc	14,181,817	$132,316,352
4	INDV	Indivior Pharmaceuticals, Inc.	1,642,086	$67,374,788
5	KNSA	Kiniksa Pharmaceuticals International, plc	957,514	$61,233,020
6	TAK	Takeda Pharmaceutical Co Ltd	3,732,924	$59,838,771
7	ANIP	Ani Pharmaceuticals Inc This page	562,016	$46,523,684
8	ELAN	Elanco Animal Health Inc	1,872,157	$46,073,783

All Filings in ANIP

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$46,523,684	562,016	-0.4%	Shares	Defined	2026-08-13
2026-03-31	$43,399,284	564,360	+19.3%	Shares	Defined	2026-05-14
2025-12-31	$37,354,960	473,207	+31.4%	Shares	Defined	2026-02-13
2025-09-30	$32,992,304	360,178	+3771.2%	Shares	Defined	2025-11-13
2024-06-30	$592,478	9,304	+10.8%	Shares	Defined	2024-08-14
2024-03-31	$580,553	8,398	-1.6%	Shares	Defined	2024-05-15
2021-12-31	$393,431	8,538	-77.3%	Shares	Defined	2022-02-14
2020-06-30	$1,215,563	37,587	-59.6%	Shares	Defined	2020-08-12
2020-03-31	$3,793,831	93,123	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.